Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2023	$ 599,502	$ 82	$ 1,143,453	$ 272	$ (544,305)
Beginning Balance (in shares) at Dec. 31, 2023		81,969,693
Vesting of restricted common stock (in shares)		7,290
Exercise of stock options	301		301
Exercise of stock options (in shares)		76,044
Issuance of common stock from At-the-Market offering, net of issuance costs of $747	22,433	$ 2	22,431
Issuance of common stock from At-the-Market offering, net of issuance costs of $747, (in shares)		1,766,835
Unrealized loss on marketable securities	(772)			(772)
Stock-based compensation	10,341		10,341
Net loss	(48,736)				(48,736)
Ending Balance at Mar. 31, 2024	583,069	$ 84	1,176,526	(500)	(593,041)
Ending balance (in shares) at Mar. 31, 2024		83,819,862
Beginning Balance at Dec. 31, 2024	$ 493,400	$ 89	1,235,897	428	(743,014)
Beginning Balance (in shares) at Dec. 31, 2024	88,758,218	88,758,218
Vesting of restricted common stock (in shares)		37,044
Exercise of stock options	$ 7		7
Exercise of stock options (in shares)	1,316	1,316
Unrealized loss on marketable securities	$ (35)			(35)
Stock-based compensation	11,174		11,174
Net loss	(31,033)				(31,033)
Ending Balance at Mar. 31, 2025	$ 473,513	$ 89	$ 1,247,078	$ 393	$ (774,047)
Ending balance (in shares) at Mar. 31, 2025	88,796,578	88,796,578